
CDMO0.00%14.3%

CRL+65.48%14.3%

DGX+32.82%14.3%

FTRE+111.98%14.3%

LH+10.03%14.3%

MRVI+172.73%14.3%

NOTV0.00%14.3%
As of Oct 2, 2026, 9:55 PM ET
MedTech Long '24: Lab Research & Trials Constituents
Avid Bioservices, Inc.CDMO | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $361.4M |
Charles River Laboratories International, Inc.CRL | 14.3% | 1.17% | 1.78% | -0.54% | 1.17% | 45.47% | 62.58% | 94.39% | 65.48% | 53.06% | -30.36% | $13.98B |
Fortrea Holdings Inc.FTRE | 14.3% | 3.09% | -0.39% | 10.84% | 4.90% | 17.97% | 89.83% | 170.97% | 111.98% | 4.82% | -33.55% | $1.90B |
Inotiv, Inc.NOTV | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -48.13% | $553.0M |
Labcorp Holdings Inc.LH | 14.3% | 1.28% | -1.31% | -7.29% | 0.94% | 22.56% | 6.35% | 30.08% | 10.03% | 43.87% | 33.03% | $25.30B |
Maravai LifeSciences Holdings, Inc.MRVI | 14.3% | 5.33% | 8.58% | 9.76% | 8.00% | 149.23% | 127.53% | 266.52% | 172.73% | 3.13% | -81.74% | $2.18B |
Quest Diagnostics IncorporatedDGX | 14.3% | 0.93% | 1.93% | -0.63% | 3.55% | 37.89% | 12.92% | 43.16% | 32.82% | 54.89% | 75.53% | $25.75B |
| Theme return | — | 1.69% | 1.51% | 0.27% | 1.03% | 36.80% | 38.09% | 84.98% | 52.96% | 40.59% | 4.92% | — |
| Average | 14.3% | 1.69% | 1.51% | 1.73% | 2.65% | 39.02% | 42.74% | 86.45% | 56.15% | 22.82% | -12.18% | $10.00B |
| Median | 14.3% | 1.17% | 0.00% | 0.00% | 1.17% | 22.56% | 12.92% | 43.16% | 32.82% | 4.82% | -30.36% | $2.18B |
| Std Dev | 0.0% | 1.77% | 3.08% | 5.92% | 2.77% | 47.73% | 47.31% | 92.30% | 60.68% | 24.32% | 49.00% | $10.74B |
| Min | 14.3% | 0.00% | -1.31% | -7.29% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -81.74% | $361.4M |
| Max | 14.3% | 5.33% | 8.58% | 10.84% | 8.00% | 149.23% | 127.53% | 266.52% | 172.73% | 54.89% | 75.53% | $25.75B |
| % Positive Tickers | 71.43% | 42.86% | 28.57% | 71.43% | 71.43% | 71.43% | 71.43% | 71.43% | 71.43% | 28.57% |